Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Egle Radice

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Oncotarget|November 22, 2017
ACKR3 expression on diffuse large B cell lymphoma is required for tumor spreading and tissue infiltrationViola Puddinu, Sabrina Casella, Egle Radice, et al.
Frontiers in Immunology|January 30, 2023
ACKR3 promotes CXCL12/CXCR4-mediated cell-to-cell-induced lymphoma migration through LTB4 productionPaola Antonello, Diego U Pizzagalli, Mathilde Foglierini, et al.
Journal of Leukocyte Biology|March 31, 2018
Characterization of a chimeric chemokine as a specific ligand for ACKR3Rafet Ameti, Serena Melgrati, Egle Radice, et al.
Plos One|November 10, 2016
CXCL4 and CXCL4L1 Differentially Affect Monocyte Survival and Dendritic Cell Differentiation and PhagocytosisMieke Gouwy, Pieter Ruytinx, Egle Radice, et al.
Plos Biology|May 9, 2023
Atlas of the anatomical localization of atypical chemokine receptors in healthy miceSerena Melgrati, Egle Radice, Rafet Ameti, et al.
Cell Reports|August 7, 2020
Marginal Zone Formation Requires ACKR3 Expression on B CellsEgle Radice, Rafet Ameti, Serena Melgrati, et al.
Frontiers in Immunology|August 9, 2023
GPR182 is a broadly scavenging atypical chemokine receptor influencing T-independent immunitySerena Melgrati, Oliver J Gerken, Marc Artinger, et al.
EMBO Molecular Medicine|June 1, 2017
CXCL12α/SDF-1 from perisynaptic Schwann cells promotes regeneration of injured motor axon terminalsSamuele Negro, Francesca Lessi, Elisa Duregotti, et al.
Nature Immunology|June 1, 2026
Regulatory factor X 7 limits Myc activity during B cell activation and suppresses Myc-dependent lymphomagenesisBerenice A Fischer, Hanif J Khameneh, Jessica Guerra, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Oncotarget|November 22, 2017
ACKR3 expression on diffuse large B cell lymphoma is required for tumor spreading and tissue infiltrationViola Puddinu, Sabrina Casella, Egle Radice, et al.
Frontiers in Immunology|January 30, 2023
ACKR3 promotes CXCL12/CXCR4-mediated cell-to-cell-induced lymphoma migration through LTB4 productionPaola Antonello, Diego U Pizzagalli, Mathilde Foglierini, et al.
Journal of Leukocyte Biology|March 31, 2018
Characterization of a chimeric chemokine as a specific ligand for ACKR3Rafet Ameti, Serena Melgrati, Egle Radice, et al.
Plos One|November 10, 2016
CXCL4 and CXCL4L1 Differentially Affect Monocyte Survival and Dendritic Cell Differentiation and PhagocytosisMieke Gouwy, Pieter Ruytinx, Egle Radice, et al.
Plos Biology|May 9, 2023
Atlas of the anatomical localization of atypical chemokine receptors in healthy miceSerena Melgrati, Egle Radice, Rafet Ameti, et al.
Cell Reports|August 7, 2020
Marginal Zone Formation Requires ACKR3 Expression on B CellsEgle Radice, Rafet Ameti, Serena Melgrati, et al.
Frontiers in Immunology|August 9, 2023
GPR182 is a broadly scavenging atypical chemokine receptor influencing T-independent immunitySerena Melgrati, Oliver J Gerken, Marc Artinger, et al.
EMBO Molecular Medicine|June 1, 2017
CXCL12α/SDF-1 from perisynaptic Schwann cells promotes regeneration of injured motor axon terminalsSamuele Negro, Francesca Lessi, Elisa Duregotti, et al.
Nature Immunology|June 1, 2026
Regulatory factor X 7 limits Myc activity during B cell activation and suppresses Myc-dependent lymphomagenesisBerenice A Fischer, Hanif J Khameneh, Jessica Guerra, et al.
Pageof 1